Stocks
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| EBITDA margin, % | ? | -35 949% | -214.3% | -131.2% | -114.4% | ||||
| Changes by years, y/y, % | +35 735pp | +83pp | -12 098% | ||||||
Iovance Biotherapeutics. EBITDA margin, %
Iovance Biotherapeutics. EBITDA margin, changes, pp
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -163.0% | -121.8% | -68.1% | -97.0% | -38.6% | -114.4% | |
| Changes by years, y/y, % | +130pp | +11pp | +34pp | +120pp | +124pp | |||
| Changes by quarters, q/q, % | +54pp | +41pp | +54pp | -29pp | +58pp | |||
